CH 9 Pharmacotherapy of the PEDIATRIC Patient

Question 1

Authorizes the FDA to contract for the testing of already approved pediatric drugs, or when the pharmaceutical company declines the option of exclusivity:

Answer 1

Best Pharmaceuticals for Children Act (BPCA)

Question 2

Method of calculating pediatric dosages using an estimate of the child’s BSA:

Answer 2

Body surface area (BSA) method

Question 3

Method of calculating pediatric dosages that requires a calculation of the number of milligrams of drug, based on the child’s weight in kilograms (mg/kg):

Answer 3

Body weight method

Question 4

Requires that a health care provider directly observe the patient swallowing the pills, whether it is in the hospital, office, or home care setting:

Answer 4

Directly observed therapy (DOT)

Question 5

Act that gave financial incentives to pharmaceutical companies to conduct pediatric research in pharmacology; in exchange for providing pediatric labeling, the legislation gives drug companies the ability to exclusively market the drug for an additional 6 months with no competition:

Answer 5

Food and Drug Administration (FDA) Modernization Act

Question 6

Chart used to plot a child’s height and weight to determine body surface area:

Answer 6

Nomogram

Question 7

Act that authorizes the FDA to require research of pediatric uses for new drugs:

Answer 7

Pediatric Research Equity Act of 2003